Insider Holders & Insider Ownership - Aileron Therapeutics Inc. (ALRN)

List of insiders holdings for Aileron Therapeutics Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
APPLE TREE PARTNERS II LP
10% Owner		2018-07-10 16:26:251,380,241
0		1,380,241Form 4
Novartis Bioventures Ltd
NOVARTIS AG
10% Owner		2020-04-16 07:28:291,199,904
0		1,199,904Form 13D
Aivado Manuel
See Remarks		2022-03-30 20:33:521,133,000
0		1,133,000Form 4/A
LV Management Group LLC
Lilly Ventures Fund I LLC
Torres S. Edward
Hall Steven Edward
Former 10% owner		2019-08-13 17:00:231,094,987
0		1,094,987Form 13D
EXCEL MEDICAL FUND LP
Gullans Steven R. Ph.D.
Blume Frederick R.
Enriquez Juan
Excel Medical Ventures LLC
10% Owner		2017-07-13 17:01:031,016,100
0		1,016,100Form 13D
Satter Muneer A
See Remarks		2024-04-16 17:16:57830,466
0		830,466Form 13D
CVF LLC
10% Owner		2017-07-05 20:26:00716,180
0		716,180Form 4
ROCHE HOLDING LTD
ROCHE FINANCE LTD
10% Owner		2017-07-05 20:27:55702,363
0		702,363Form 4
Apple Tree Partners II - Annex L.P.
10% Owner		2018-07-10 16:27:51655,797
0		655,797Form 4
KCK LTD.
10% Owner		2017-07-05 20:28:38646,817
0		646,817Form 4
AJU IB Investment Co. Ltd.
10% Owner		2017-07-07 19:13:330
517,558		517,558Form 4
GLAXOSMITHKLINE PLC
10% Owner		2020-02-14 16:38:33504,926
0		504,926Form 13D
Sigma Emerging Markets Ltd.
10% Owner		2017-07-06 18:25:03423,086
0		423,086Form 4
Wanstall Rick
See Remarks		2022-03-30 20:32:10393,000
0		393,000Form 4/A
Garner Charles
Senior Vice President, Finance		2024-04-02 18:10:42375,347
0		375,347Form 3
Annis Allen
SVP, Research		2022-03-30 20:31:54313,000
0		313,000Form 4/A
Gregory Kathryn
SVP, Chief Business Officer		2020-02-04 16:30:40185,000
0		185,000Form 4
Yanchik Joseph A. III
See Remarks		2017-07-27 18:35:57157,449
0		157,449Form 4
Vukovic Vojo
Chief Medical Officer		2022-03-30 20:32:28150,000
0		150,000Form 4/A
Dougherty Donald
SVP & Chief Financial Officer		2019-04-17 18:44:47150,000
0		150,000Form 4
Platt Jon B.
10% Owner		2017-07-05 20:28:2790,318
0		90,318Form 4
Bailey Jeffrey Allen
Director		2022-06-17 17:10:4954,500
0		54,500Form 4
Sigal Nolan Howard
Director		2022-06-17 17:12:3254,500
0		54,500Form 4
MCKEE WILLIAM
Director		2022-06-17 17:18:2754,500
0		54,500Form 4
Morrison Jodie Pope
Director		2022-06-17 17:22:1954,500
0		54,500Form 4
Nelson Kira
See Remarks		2017-07-27 18:42:2036,844
0		36,844Form 4
MCARTHUR JOHN H
Director		2019-06-21 16:07:5525,000
0		25,000Form 4
Gallagher Brian M. Jr.
Director		2017-07-27 18:27:5120,000
0		20,000Form 4
LONGENECKER JOHN P PHD
President and CEO		2018-08-14 19:38:2410000
0		10000Form 4
Shanafelt Armen
Director		2018-06-25 18:25:4910000
0		10000Form 4
Winder Caleb Maxfield
Director		2018-06-25 18:13:4710000
0		10000Form 4
WINDSOR JAMES BRIAN
President and COO		2024-03-06 17:06:157122
225		7347Form 4
Musso Alan A
Director		2023-11-02 20:53:075450
0		5450Form 4
Fairey William
Director		2023-11-02 20:55:225450
0		5450Form 4
Ambros Reinhard J.
Director		2024-04-10 16:15:052725
0		2725Form 4/A
VON RICKENBACH JOSEF H
Director		2024-04-10 16:15:092725
0		2725Form 4/A
Drexler Susan L.
See Remarks		2022-06-17 17:12:170
0		0Form 3
Kapnick Scott
Director
10% Owner		2024-02-05 13:20:210
0		0Form 13G